feed,title,long_url,short_url
SeekingAlpha,ClearBridge Appreciation Strategy Portfolio Manager Commentary Q1 2021,https://seekingalpha.com/article/4422475,
SeekingAlpha,"Iterum Therapeutics: Delayed Review Of Its NDA For Sulopenem, But Upside Still Exists",https://seekingalpha.com/article/4422453,
